EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The role of microbiome in immunotherapy: Insights and perspectives

Meilin Ye, Houyu Ju, Guoxin Ren, Jingzhou Hu

Seminars in Cancer Biology · 2025-12 · 117 · 131-151

DOI: 10.1016/j.semcancer.2025.11.001 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Cancer Biology, 2025-12. Verfasst von Meilin Ye und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Maxillofacial & Head and Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Colleg…. Hauptthemen laut MEDLINE: Immunotherapy, Neoplasms, Gastrointestinal Microbiome, Microbiota. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 218 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The intricate interplay between the gut microbiome and the host immune system has been recognized as a pivotal determinant of clinical outcomes in cancer immunotherapy. Mounting evidence suggests that specific microbial communities are associated with both the efficacy and toxicity of immune checkpoint inhibitors in diverse malignancies, underscoring the microbiome's role in modulating systemic and tumour-localized immunity. Mechanistically, the microbiome shapes antitumour immunity by affecting antigen presentation, activation of effector cells, immunosuppression and adverse effects. Key microbial components and metabolites present in distinct anatomical niches have been identified as promoters or inhibitors of therapeutic responsiveness via multiple pathways. Harnessing this knowledge, microbiome-targeted strategies such as antibiotic, probiotic, fecal microbiota transplantation, and dietary modulation are regarded as potential adjuvant therapies to enhance the efficacy of anti-tumour therapies. Although significant progress has been achieved in preclinical studies, challenges persist in translating these findings into standardized clinical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyNeoplasmsGastrointestinal MicrobiomeMicrobiotaHumansAnimalsFecal Microbiota TransplantationProbioticsImmune Checkpoint Inhibitors

Stichwörter der Autor:innen

CancerImmunotherapyMicrobiomeTumour microenvironment

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Oral Maxillofacial & Head and Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, College of Stomatology, Shanghai Jiao Tong University, Shanghai, 200011, PR…

Zitieren

APA

Ye, M., Ju, H., Ren, G., & Hu, J. (2025). The role of microbiome in immunotherapy: Insights and perspectives. Seminars in Cancer Biology, 117, 131-151. https://doi.org/10.1016/j.semcancer.2025.11.001

Vancouver

Ye M, Ju H, Ren G, Hu J. The role of microbiome in immunotherapy: Insights and perspectives. Seminars in Cancer Biology. 2025;117:131-151. doi:10.1016/j.semcancer.2025.11.001

BibTeX
@article{Ye2025,
  author = {Ye, Meilin and Ju, Houyu and Ren, Guoxin and Hu, Jingzhou},
  title = {The role of microbiome in immunotherapy: Insights and perspectives},
  journal = {Seminars in Cancer Biology},
  year = {2025},
  volume = {117},
  pages = {131--151},
  doi = {10.1016/j.semcancer.2025.11.001}
}
Kostenlos starten →